Genetic Testing for Selection of Psychotropic Medications

GeneSight is a blood test to determine which neuropsychiatric medications are indicated for an individual based on genetic analysis. The test is expensive and not likely to be helpful for most patients. Patients who suffer from major depression and other neuropsychiatric conditions usually improve with medication, but about half of patients fail to respond to

Scroll to top